European Archives - Page 280 of 1587 - European Medical Journal

S100A11 -HK2

S100A11-HK2 Axis Emerges as Promising Target in MASH

Silencing S100A11 protects against steatosis, inflammation and fibrosis in murine MASH, uncovering HK2 as a key metabolic driver and potential therapeutic target.

igh Cardiorespiratory Fitness Linked to Lower Risk of Urinary Tract Cancers

High Cardiorespiratory Fitness Linked to Lower Risk of Urinary Tract Cancers

A large Norwegian study shows that higher cardiorespiratory fitness is linked to a significantly lower long-term risk of urinary tract, bladder, and kidney cancers.

dementia biomarkers

Dementia Biomarkers Track Early Cognitive Decline

Blood based dementia biomarkers reveal which patients with memory concerns are most likely to worsen.

Kefir Shows Potential as a Natural Strategy for Osteoporosis Management

A new review highlights kefir-derived peptides, probiotics and kefiran as promising natural strategies for bone health and osteoporosis prevention.

Personalised CRISPR Therapy Success in Baby With Rare Disorder

A world-first personalised CRISPR base-editing therapy has shown promising early results in an infant with CPS1 deficiency, demonstrating the potential of rapid, bespoke gene-editing treatments for ultra-rare genetic diseases.

pancreatic cancer

Targeted Drug Shows Promise in Aggressive Pancreatic Cancer

Garsorasib shrank tumours in nearly half of patients with KRAS G12C pancreatic cancer and showed manageable side effects.

IMCAS World Congress 2026: Shaping the Future of Dermatologic Science and Patient Safety

IMCAS World Congress 2026 unites global dermatology experts to explore advances in science, aesthetics, and complication management across lasers, dermatology, and injectables.

Ivarmacitinib Ointment

New Ivarmacitinib Ointment Shows Strong Results for Eczema Treatment

New phase 3 trial finds ivarmacitinib ointment provides rapid, lasting relief from mild-to-moderate eczema with a favourable safety profile.

5 Dec 2025

Experts Clear the Air on the Burden of CRSwNP

Chronic rhinosinusitis is a chronic inflammatory condition of the paranasal sinuses and nasal cavities, affecting an estimated 2–12% of the…

Sponsored Content: Optimal Care of Unfit Patients with FTL3+ AML

This publication is intended for healthcare professionals only and has been commissioned and funded by Astellas Pharma Ltd.